Skye Bioscience – CFN Media

Skye Bioscience Uplists to The Nasdaq Global Market

SAN DIEGO, CA, April 10, 2024 — Skye Bioscience, Inc. (OTCQB: SKYE)…

Ryan Allway
April 10, 2024

Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody

Acquisition of Bird Rock Bio builds Skye’s position as a leading endocannabinoid…

Ryan Allway
August 21, 2023

Skye Bioscience Completes Enrollment of Phase 1 Clinical Trial of Novel CB1R Agonist, SBI-100 Ophthalmic Emulsion

SKYE COMPLETES DOSING OF FINAL COHORT OF HEALTHY VOLUNTEERS IN STUDY OF…

Ryan Allway
June 12, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Investing in Plastic Recycling Technology

Plastic waste is widely recognized as a major problem that needs to…

Robin Lefferts
November 21, 2024

Cardiol’s Favorable Phase 2 Results Set the Table for Advanced Clinical Trials

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) recently presented excellent…

Robin Lefferts
November 20, 2024

Aduro Clean Technologies Engages Global Leader Zeton for Design and Fabrication of Hydrochemolytic™ Pilot Plant

Milestone Project to Demonstrate Aduro’s Modular, Scalable Solution for Converting…

Ryan Allway
November 19, 2024

IKE Tech LLC and Ispire Technology Inc. Announce Positive Pre-PMTA Submission Meeting with the FDA

Seeks Authorization for Pioneering Point-of-Use Identity and Age Verification…

Ryan Allway
November 18, 2024